The findings demonstrated that high levels of MMP11 in patients with EGFR-mutant LUAD are associated with a poor immune response and may control the tumor immune microenvironment, which fosters an immunosuppressive environment and aids in the immune escape of tumor cells. Here, EGFR is linked to neoplasm.